Susanna Tokola

Interim and end‐of‐treatment PET‐CT suffers from high false‐positive rates in DLBCL: Biopsy is needed prior to treatment decisions

T. Turpeenniemi‐Hujanen, O. Kuittinen, H. Kuitunen, 2021, Cancer medicine.

Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL)

Seppo Alahuhta, Outi Kuittinen, S. Alahuhta, 2016, Journal of Neuro-Oncology.

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients

T. Turpeenniemi‐Hujanen, O. Kuittinen, H. Kuitunen, 2020, Cancer medicine.

Drug‐induced pneumonitis risk in diffuse large B‐cell/follicular lymphoma patients treated with R‐CHOP‐like regimen is associated with the use of granulocyte colony‐stimulating growth factors

T. Turpeenniemi‐Hujanen, O. Kuittinen, M. Kuusisto, 2024, Cancer medicine.